Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- Stock Picks For Healthy Returns
Nov 25, 2008 10:19 AM
- King's Shares Jump On Securing $1.6 Billion Takeover Bid For Alpharma
Nov 24, 2008 02:24 PM
- Full Calendar On Tap for FDA Through Year-End
Nov 13, 2008 06:23 PM
- A Backlog Of Decisions Is Building At The FDA
Nov 07, 2008 11:48 AM
- Durect Headed in Right Direction - Analyst Blog
Nov 04, 2008 05:02 PM
- Earnings Review: AET, ANR, ALO, CAH, GLW
Oct 29, 2008 12:48 PM
- Weekly Mergers and Acquisitions Report
Oct 21, 2008 08:56 AM
- Best Perfomers Over Last Quarter
Oct 06, 2008 02:19 AM
- King Pharmaceuticals: New Drugs Set To Deliver
Sep 23, 2008 06:52 PM
- Pros and Cons of Owning Mylan Inc
Sep 10, 2008 09:51 PM
- In Brief
Nov 25, 2008 07:13 AM
- Citigroup, Campbell Soup, Alpharma big movers
Nov 24, 2008 09:21 PM
- Movers: WaMu, JPMorgan, Research in Motion, Accenture
Sep 29, 2008 10:52 AM
- Palo?'s Present
Sep 27, 2008 09:55 AM
- Saturn Dealer Trims 30 Jobs
Sep 05, 2008 08:57 AM
- Stocks End Week With a Rally
Aug 25, 2008 10:53 AM
- Movers: Lehman, Alpharma, Google, Intuit, Gap, Pacific Sunwear
Aug 25, 2008 10:53 AM
- King Pharmaceuticals To Acquire Alpharma for Approximately $1.6 Billion
Nov 24, 2008 08:01 AM
- Zacks #1 Rank Top Performers: American Science and Engineering, Allegiant Travel, Alpharma, Hanger Orthopedic and Emergency Medical Services
Nov 18, 2008 03:21 PM
- DURECT's Collaboration With Alpharma Clears HSR Review and Is Effective
Oct 29, 2008 07:01 AM
- Alpharma Reports Third Quarter 2008 EPS of $0.10
Oct 29, 2008 07:00 AM
- Alpharma Announces Information for Third Quarter 2008 Earnings Conference Call
Oct 24, 2008 04:05 PM
- Zacks Analyst Blog Highlights: Johnson & Johnson, CarMax, Inc., Rackable Systems, Inc., DURECT Corp. And Alpharma Inc.
Oct 20, 2008 01:13 AM
- National Family Partnership Designates October 27th 'Lock Your Meds' Day
Oct 15, 2008 01:32 PM
- King Pharmaceuticals Extends Tender Offer to Acquire Alpharma
Oct 13, 2008 07:06 AM
- Alpharma Board of Directors Unanimously Rejects King Pharmaceuticals' Unsolicited Tender Offer as "Financially Inadequate"
Sep 26, 2008 07:23 AM
- Alpharma to Develop and Commercialize DURECT's ELADUR(TM) Pain Patch
Sep 22, 2008 07:01 AM
Analyst Ratings
|
|
Share Performance
|
Period
|
ALO
|
Compare to S&P
|
| YTD |
79.16 %
|
193.52 %
|
| 4 Weeks |
15.30 %
|
24.63 %
|
| 12 Weeks |
1.46 %
|
40.64 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 600.00 %
|
|
EPS Growth in Last Year: -70.59 %
|
|
Sales Growth in Last Quarter: 5.27 %
|
|
Sales Growth in Last Quarter: -0.06 %
|
|
|
